Cancer Gene Therapy
Collection
Collection
- ISSN: 09291903
Published by Nature Publishing Group NPG (MacMillan)
-
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer Article
Cancer Gene Therapy, 9(7), 613-623.C.H.J. Lamers (Cor), R.A. Willemsen (Ralph), B.A. Luider (Barbara), J.E.M.A. Debets (Reno) and R.L.H. Bolhuis (Reinder)
January 2002 -
Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer Article
Cancer Gene Therapy, 13(5), 503-509.C.H.J. Lamers (Cor), R.A. Willemsen (Ralph), P.M.M.L. van Elzakker (Pascal), B.A. van Krimpen (Brigitte), J.W. Gratama (Jan-Willem) and J.E.M.A. Debets (Reno)
May 2006 -
Human adenovirus type 35 vector for gene therapy of brain cancer: Improved transduction and bypass of pre-existing anti-vector immunity in cancer patients Article
Cancer Gene Therapy, 14(2), 211-219.E. Brouwer (Eric), M.J. Havenga, O. Ophorst, B.H.C.G.M. de Leeuw (Bertie), L. Gijsbers, G. Gillissen, R.C. Hoeben (Rob), M. ter Horst (Maarten), D. Nanda, C.M.F. Dirven (Clemens), et al. C.J.J. Avezaat (Cees), J. Goudsmit (Jaap) and P.S. Smitt
February 2007 -
Retroviral vectors for clinical immunogene therapy are stable for up to 9 years Article
Cancer Gene Therapy, 15(4), 268-274.C.H.J. Lamers (Cor), P.M.M.L. van Elzakker (Pascal), B.A. Luider (Barbara), S.C.L. van Steenbergen, S. Sleijfer (Stefan), J.E.M.A. Debets (Reno) and J.W. Gratama (Jan-Willem)
April 2008 -
Heterogeneous reovirus susceptibility in human glioblastoma stem-like cell cultures Article
Cancer Gene Therapy, 20(9), 507-513.S.K. van den Hengel (Sanne), R.K. Balvers (Rutger), I.J.C. Dautzenberg (Iris), D.J.M. van den Wollenberg (Diana), J.J. Kloezeman (Jenneke), M.L.M. Lamfers (Martine), P.A.E. Sillivis-Smit and R.C. Hoeben (Rob)
September 2013 -
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection Article
Cancer Gene Therapy, 21(1), 24-30.P.R.A. Buijs (Pascal), C.H.J. van Eijck (Casper), L.J. Hofland (Leo), R.A.M. Fouchier (Ron) and B.G. van den Hoogen (Bernadette)
January 2014 -
Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy Article
Cancer Gene Therapy, 21(11), 463-471.P.R.A. Buijs (Pascal), G. Van Amerongen, S. van Nieuwkoop (Stefan), T.M. Bestebroer (Theo), P.R.W.A. van Run (Peter), T. Kuiken (Thijs), R.A.M. Fouchier (Ron), C.H.J. van Eijck (Casper) and B.G. van den Hoogen (Bernadette)
January 2014 -
Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer Article
Cancer Gene Therapy, 23(6), 168-177.R. Zhang (Rong), Zhang, X., B. Ma (Buyun), Xiao, B., F. Huang (Fang), Huang, P., Ying, C., Liu, T. and Y. Wang (Ye)
June 2016